Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 382

1.

Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.

Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, Shingai T, Elashoff DA, Ye X, Singer FR, Giuliano AE, Hoon DS.

Clin Cancer Res. 2007 Jul 15;13(14):4105-10.

2.

Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.

Wascher RA, Bostick PJ, Huynh KT, Turner R, Qi K, Giuliano AE, Hoon DS.

Br J Cancer. 2001 Nov 2;85(9):1340-6.

3.

Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.

Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS.

Cancer Res. 2001 Dec 15;61(24):8845-50.

4.

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.

Wülfing P, Borchard J, Buerger H, Heidl S, Zänker KS, Kiesel L, Brandt B.

Clin Cancer Res. 2006 Mar 15;12(6):1715-20.

5.

Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.

Gimbergues P, Dauplat MM, Cayre A, Durando X, Le Bouedec G, Finat-Duclos F, Portefaix G, Kwiatkowski F, Dauplat J, Penault-Llorca F, Tchirkov A.

Eur J Surg Oncol. 2007 Feb;33(1):16-22. Epub 2006 Oct 27.

PMID:
17071045
6.

Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.

Jinno H, Sakata M, Asaga S, Wada M, Shimada T, Kitagawa Y, Suzuki T, Nakahara T, Kitamura N, Kubo A, Mukai M, Ikeda T, Kitajima M.

Breast J. 2008 Nov-Dec;14(6):551-5. doi: 10.1111/j.1524-4741.2008.00646.x. Epub 2008 Oct 13.

PMID:
19000054
7.

Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.

Yie SM, Luo B, Ye NY, Xie K, Ye SR.

Clin Exp Metastasis. 2006;23(5-6):279-89. Epub 2006 Nov 3.

PMID:
17086357
8.

A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems.

Cho J, Han W, Lee JW, Ko E, Kang SY, Jung SY, Kim EK, Moon WK, Cho N, Park IA, Chung JK, Hwang KT, Kim SW, Noh DY.

Ann Surg Oncol. 2008 Aug;15(8):2278-86. doi: 10.1245/s10434-008-9993-z. Epub 2008 Jun 5.

PMID:
18528729
9.

Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.

Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B.

Clin Cancer Res. 2005 Mar 15;11(6):2156-62.

10.

Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.

Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, Kafousi M, Chlouverakis G, Stathopoulos E, Lianidou E, Georgoulias V, Mavroudis D.

Clin Cancer Res. 2008 May 1;14(9):2593-600. doi: 10.1158/1078-0432.CCR-07-4758.

11.

Possible predictive markers related to micro-metastasis in breast cancer patients.

Zhu L, Loo WT, Cheng CW, Chow LW.

Oncol Rep. 2006 May;15(5):1217-23.

PMID:
16596190
12.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039
13.

Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.

Manca G, Romanini A, Pellegrino D, Borsò E, Rondini M, Orlandini C, Zucchi V, Pasqualetti F, Mariani G.

J Nucl Med. 2008 Nov;49(11):1769-75. doi: 10.2967/jnumed.108.055350. Epub 2008 Oct 16.

14.

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D.

J Clin Oncol. 2007 Nov 20;25(33):5194-202. Epub 2007 Oct 22.

15.

Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.

Nissan A, Jager D, Roystacher M, Prus D, Peretz T, Eisenberg I, Freund HR, Scanlan M, Ritter G, Old LJ, Mitrani-Rosenbaum S.

Br J Cancer. 2006 Mar 13;94(5):681-5.

16.

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.

Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.

Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.

PMID:
18616789
17.

Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial.

Koyanagi K, Bilchik AJ, Saha S, Turner RR, Wiese D, McCarter M, Shen P, Deacon L, Elashoff D, Hoon DS.

Clin Cancer Res. 2008 Nov 15;14(22):7391-6. doi: 10.1158/1078-0432.CCR-08-0290.

18.

Prediction of breast tumor progression by integrity of free circulating DNA in serum.

Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, Hoon DS.

J Clin Oncol. 2006 Sep 10;24(26):4270-6.

19.

Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.

Stathopoulos EN, Sanidas E, Kafousi M, Mavroudis D, Askoxylakis J, Bozionelou V, Perraki M, Tsiftsis D, Georgoulias V.

Ann Oncol. 2005 Feb;16(2):240-6.

20.

Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.

Langer I, Guller U, Hsu-Schmitz SF, Ladewig A, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.

Eur J Surg Oncol. 2009 Aug;35(8):805-13. doi: 10.1016/j.ejso.2008.09.006. Epub 2008 Nov 28.

PMID:
19046846
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk